StockMarketWire.com - Deltex Medical Group, the global leader in oesophageal Doppler monitoring, has launched TruFlow, a new, wider beam, single patient disposable probe in the UK and US. The reconfigured probe tip design creates a wider ultrasound beam at the focal point in the aorta.
Extensive clinical testing in UK hospitals, has confirmed most doctors find that the new probes are easier to focus and that they maintain focus substantially better, even when the patient's position is changed. The TruFlow probe has been used in all new evaluations in the US since November.
Deltex Medical chief executive Ewan Phillips said: "The new wider beam of the TruFlow probes are a major step-forward for Deltex as making the proven ODM technology even easier to use, reduces perceived barriers to change in clinical practice and further reduces the clinical support needed before new customers become independent users."
At 8:06am: [LON:DEMG] Deltex Medical Group PLC share price was +0.13p at 4p
Story provided by StockMarketWire.com
Shares Magazine
Shares is the leading weekly publication for retail investors. It is packed with investment ideas, news and educational material to help build and run portfolios and get more from your money.
Investor Events
Shares puts on free Investor Events throughout the year across the country. They provide an opportunity for investors to learn more about companies on the stock market and hear from a range of investment experts including fund managers and Shares journalists.